Back to company

2care4 Generics ApS: Financial statements 2020

CVR: 36960566

2care4 Generics ApS (CVR 36960566) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 32,852,182 and a net result of DKK 15,714,624 compared with DKK -599,230 the year before. That is an increase of 311.2% compared with the year before. Equity amounted to DKK 15,549,059. The solvency ratio was 21.5%. The company had 12 employees in the financial year.

Gross Profit
32,852,182 kr.
Profit/Loss
15,714,624 kr.
Equity
15,549,059 kr.
Total Assets
72,432,512 kr.
Employees
12

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-32.9 mio.15.7 mio.15.5 mio.12
2019-8 mio.-599 t.-166 t.8
2018-3.3 mio.-2.9 mio.434 t.7
2017--1.5 mio.-6 mio.330 t.5

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is 2care4 Generics ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

2care4 Generics ApS: The 2019 annual report is outJun 9, 2020

2care4 Generics ApS has published its annual report for 2019. Gross profit came to DKK 7,988,765, and the net result was DKK -599,230.

About 2care4 Generics ApS

2care4 Generics ApS is a Danish company of the type Anpartsselskab based in Esbjerg V, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Erik Sandberg. The company is owned by 2care4 Group ApS. The company has 7 employees. In 2025, the company reported a gross profit of DKK 52,415,000 and a net result of DKK 11,207,000 compared with DKK 17,193,000 the year before. Equity amounted to DKK 49,944,000.